HOTH - CONSENSUS CO - Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc. (HOTH) possesses high growth potential due to patents for skin treatments that ensure minimal production costs alongside global distribution. The company currently generates no commercial revenue, meaning its pricing power depends on trial outcomes, with the metric standing at . The price action reflects the development of a startup that attracts experts through agile management and stock options.

This indicator reflects the weighted average target price of the asset, derived from investment bank expert estimates to determine fundamental growth potential. Professional investors utilize the consensus target price forecast to compare the market price with the expected value of Hoth Therapeutics, Inc. (HOTH), given that a lack of sales and pricing power makes the company's valuation dependent on clinical trial outcomes.